Radioactive Nanoparticles Against Prostate Cancer

  • Author: ChemistryViews.org
  • Published: 26 January 2017
  • Copyright: Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
  • Source / Publisher: Advanced Healthcare Materials/Wiley-VCH
thumbnail image: Radioactive Nanoparticles Against Prostate Cancer

Brachytherapy, the implantation of radioactive material directly into a tumor, is commonly used against prostate cancer. The treatment is often effective, and the radiation is contained inside the tumor. However, the method requires the insertion of dozens of millimeter-sized radioactive metal seeds, which remain in the prostate permanently. This causes discomfort and swelling.


Marc-André Fortin, Université Laval, Québec, Canada, and colleagues have developed radioactive gold nanoparticles (NPs) with palladium cores (pictured). Solutions of NPs can be injected with small needles, which makes the treatment less invasive than with millimeter-sized metal particles. The team prepared palladium nanoparticles doped with radioactive 103Pd from a H2PdCl4/103PdCl2 precursor solution. They then added a HAuCl4 solution to coat the Pd NPs with gold. In a final step, they used NH2-PEG-SH (PEG = polyethylene glycol) to graft a stabilizing PEG layer onto the particles.


The team tested the radioactive NPs in mice which were injected with human prostate cancer cells. The particles remained in the tumors for weeks and inhibited tumor growth. According to the researchers, this method could allow tuning the dose of radioactivity, is less invasive than current technologies, and also leads to fewer artifacts, e.g., in computed tomography (CT), than larger metal particles.


 

Article Views: 1160

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

Bookmark and Share

If you would like to reuse any content, in print or online, from ChemistryViews.org, please contact us first for permission. more


CONNECT:

ChemistryViews.org on Facebook

ChemistryViews.org on Twitter ChemistryViews.org on YouTube ChemistryViews.org on LinkedIn Sign up for our free newsletter


A product of ChemPubSoc Europe (16 European Chemical Societies)and Wiley-VCH